BioProcess International Conference & Exhibition 2017
September 25 – 28, 2017, Boston, MA
We are excited for this year’s BioProcess International Conference and Exposition in Boston. Visit booth 1328 and discover how Aragen Bioscience can move your pre-clinical research projects forward.
Stay Ahead with Aragen
Adopting newly-introduced and even pre-commercial technologies enables us to stay ahead of the curve, accelerating development and increasing data quality.
We’ve recently improved our development process, significantly reducing the time to purify and formulate human IgG from transient system cultures. One key technology in this new streamlined process is the GORE™ Protein Capture Device with Protein A. Want to learn more? GORE development staff will be available from 4:00-6:00 PM on Tuesday, September 26 at our booth (#1328) to discuss how this technology can advance your projects. Can’t make it? Let us know you’re interested.
We have also recently collaborated with a leading instrumentation vendor to test a new technology that improves the BioProduction process. We’ll be presenting the results of the collaboration at BPI:
Comparing Bioreactor Antibody Titer Measurements Obtained in Real Time to Other Antibody Measuring Techniques, Poster C27
Request a poster pre-print.
- Optimizing Effector Functions of Therapeutic Antibodies & Biosimilars Using a Diverse Portfolio of Biophysical and Functional Cell-Based Assays
- A Comprehensive Portfolio of In Vitro and In Vivo Assays for the Characterization and Development of Novel Anti-TNFa Biologics
- Custom Monoclonal Antibodies for Therapeutic and Diagnostic Targets – A One-Stop-Shop for Pre-Clinical Antibody Research
- In Vivo Models and In Vitro Assays for Human RSV Infection – Pre-Clinical Antibody, Small Molecule and Vaccine Development